Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: Role of beta-blocker or amiodarone treatment

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 6, 2003, Pages 578-583

  Ermis, Cengiz ^a   Zadeii, Gino ^a   Zhu, Alan X ^a   Fabian, William ^a   Collins, Joanne ^a   Lurie, Keith G ^a   Sakaguchi, Scott ^a   Benditt, David G ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiac transplantation; Implantable cardioverter defibrillator

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEFIBRILLATOR; FEMALE; HEALTH CENTER; HEART DEATH; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CARDIOMYOPATHIES; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 0038482202     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.02590.x     Document Type: Article

References (18)

1. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ: The Registry of the International Society for Heart and Lung Transplantation: Eighteenth official report-2001. J Heart Lung Transplant 2001;20:805-815.
2. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E: Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92:3593-3612.
3. Schmidinger H: The implantable cardioverter defibrillator as a "bridge to transplant": A viable clinical strategy? Am J Cardiol 1999;83(5B) 151D-157D.
4. Buxton AE, Lee KL, DiCarlo L, Echt DS, Fisher JD, Greer GS, Josephson ME, Packer D, Prystowsky EN, Talajic M: The Multicenter UnSustained Tachycardia Trial (MUSTT) Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber O, Brown MW, Iteo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
6. Moss AJ, Zareba W, Hall WJ, and The Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
7. Saxon LA, Wiener I, DeLurgio DB, Natterson PD, Laks H, Drinkwater DC, Stevenson WG: Implantable defibrillators for high risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995;130:501-506.
8. Bolling SF, Deeb GM, Morady F, Kadish A, Stirling MC, deBuitleir M, Kirsh MM: Automatic internal cardioverter defibrillator: A bridge to heart transplantation. J Heart Lung Transplant 1991;10:562-566.
9. Jeevanandam V, Bielefeld MR, Auteri JS, Sanchez JA, Schenkel FA, Michler RE, Smith CR, Livelli F Jr, Bigger JT Jr, Rose EA: The implantable defibrillator: An electronic bridge to cardiac transplantation. Circulation 1992;86(Suppl 2):II-276-II-279.
10. Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW: Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995;92:3273-3281.
11. Sandner SE, Wieselthaler G, Zuckermann A, Taghavi S, Schmidinger H, Pacher R, Ploner M, Laufer G, Wolner E, Grimm M: Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001;104(12 Suppl 1):171-176.
12. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG: Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323-1328.
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Cox DR: Regression models and life tables. J R Star Soc 1971;B34:187-220.
15. Luu M, Stevenson WG, Stevenson LW, Walden J: Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675-1680.
16. Anonymous. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. DEFIBRILAT Study Group. Am J Cardiol 1991;68:545-546.
17. Evans RW, Manninen DL, Dong FB: The National Heart Transplantation Study: Final report. Seattle, WA: Battelle Human Affairs Research Centers, 1991.
18. Klein H, Auricchio A, Reek S, Geller C: New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999;83(5B):91D-97D.